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Exposure to relative chemicals has been shown to induce a genotoxic effect that can be 
observed through formation of micronucleus (MN) in polychromatic erythrocythes (PCE). Rumput 
Mutiara or Hedyotis corymbosa L. ethanolic extract (HcEE) is known to contain ursolic acid as major 
compound that possesses antigenotoxic activity on HepG2 cells. This study exerts in vivo approach 
aiming to evaluate the antigenotoxic effects of HcEE on cyclophosphamide (CP)-induced male 
Swiss mice. The ursolic acid on HcEE was determined by using thin layer chromatography with 
silica gel as stationary phase and chloroform-aceton (9:1) as mobile phase. The antigenotoxic 
activity was carried out by in vivo micronucleus test. Twenty four adult mice were equally divided 
into seven groups. Group I: control (untreated); group II: Na-CMC 0.5%; group III: CP 50 mg/kg 
BW; group IV: CP+HcEE 250 mg/kg BW; group V: CP+HcEE 500 mg/kg BW; group VI: CP+HcEE 
1000 mg/kg BW; group VII: HcEE 1000 mg/kg BW. HcEE were given for seven days, while CP was 
administered on the last two days. On the seventh day, the peripheral blood from all mice were 
collected, smeared, and then stained with Giemsa. The frequencies of MNPCEs and %PCEs were 
evaluated. Molecular docking was performed to know the interaction between ursolic acid and 
CYP3A4 by using PLANTS software. There was similar hRF spot between HcEE with ursolic acid 
standard reference indicated that the extract almost positively contain ursolic acid. HcEE reduced 
MNPCEs significantly compared to CP group (p<0.05) and combination of CP with HcEE showed 
reduction of %PCEs (p<0.05). Based on molecular docking analysis, ursolic acid gave lower docking 
score than CP against CYP3A4 (PDB ID: 2V0M) and similar binding site on amino acid residues Ala 
448, Ile 369, Thr 309, and Val 313. All of these data suggest that HcEE perform protective effect 
against CP-induced genotoxicity. 
 





Over exposure of reactive chemicals from 
food, air, water, or from metabolic products to 
human body has been shown to induce a genotoxic 
effect through DNA damage (Wogan, et al., 2004). 
Generally, DNA damage is triggered by ROS 
(Reactive Oxygen Species) produced by endogenous 
metabolites or exogenous chemicals that are 
activated by metabolism within cells (Bont and 
Larebeke, 2004). DNA damage is the beginning of 
mutation and cancer incidence which need to pay 
extra attention for the prevention. Unfortunately, the 
radical species may come from some particular 
drugs which essential to cure cancer, such as 
chemotherapeutic agents (Higuchi, 2003). In some 
cases, the use of chemotherapeutic agent rises 
cellular damage leading to new cancer clone. Such 
kind of these chemotherapeutic agents have 
characteristic as alkylating agent that reactively 
forming the covalent bound with DNA by which 
ROS as its the intermediate form. 
Cyclophosphamide is one of the chemotherapeutic 
agents whose exerts the same mechanism 
(McCarroll, et al., 2008). Nonetheless, take into 
account that chemotherapeutic agents are important 
in cancer therapy it is necessary to find ways for 






*Corresponding author e-mail: edy_meiyanto@ugm.ac.id 
Aprianto, et al., 2017 




Actually radical species can be neutralized 
naturally by antioxidant enzymes, e.g., SOD 
(superoxide dismutase), GPX (glutathione 
peroxidase), GR (glutathione reductase), HO (heme 
oxgenase), catalase, etc. (Bhattacharyya, et al., 
2014). However, the constitutive expression of 
enzymes cannot neutralize properly the abundant 
ROS (Wang, et al., 2011). Therefore the 
administration of antioxidants from external sources 
is a strategic way to overcome this condition. 
The purpose of this study is to evaluate the 
activity of Rumput Mutiara or Hedyotis corymbosa 
L. ethanolic extract (HcEE) in overcoming genotoxic 
effects of cyclophosphamide (CP) through in vivo 
and molecular docking study. In vitro study revealed 
that methanolic extract of Hedyotis corymbosa L. 
present high antioxidant activity that responsible for 
counteracting free radicals and inhibiting ROS 
formation (Uttara, et al., 2009; Sasikumar, et al., 
2010). Particularly, it is known to contain ursolic 
acid as the active compounds (Chen, et al., 2005). 
Beside antioxidant properties, the ursolic acid is also 
reported to exhibit chemopreventive and 
antimutagenic effect (Martin-Aragon, et al., 2001; 
Ramos, et al., 2008). Thus, HcEE can be predicted to 
possess activity as well as antigenotoxic agent.  
 
MATERIALS AND METHODS 
 
Extract Preparation 
Wet herb of Hedyotis corymbosa were 
collected from Yogyakarta, Indonesia, then was 
determined at Biological Pharmacy Laboratory, 
UGM.  The simplicia were blended to powder form 
then macerated with 96% ethanol (1:1) for three 
days and remacerated for two days. The macerate 
was dried using rotary evaporator on 40ºC. 
Identification of chemical compound in HcEE were 
monitored using TLC analysis by used ursolic acid 
as reference standard, chloroform: aceton (9:1 v/v) 
as the mobile phase while the stationary phase is 
silica gel F254.  
 
Chemicals 
Cyclophosphamid (Kalbe), Aquades (Asia 
Lab), Na-CMC (Sigma), Giemsa staining (Aldrich), 
Xylol (Aldrich), Entellan® Neu (Aldrich), Ethanol 




Forty two Swiss male mice aged 6-7 weeks 
with 23-29 gram weight obtained from Health 
Research and Development Agency (Litbangkes) 
Ministry of Health Republic of Indonesia in Jakarta. 
Then the test animal was adapted for one week 
before treatment began (acclimatization). The test 
animals were divided into seven treatment groups 
consisting of six mice each (Table I). Each group of 
mice is placed in a plastic box that is different from 





C and humidity of 70-80%. 
 
In Vivo Micronucleus Test 
In vivo micronucleus test was carried out 
based on the method developed by Krishna and 
Hayashi (2010). Briefly, all mice were divided into 
seven groups, as follow:  
(a) Group 1: Untreated 
(b) Group 2: Na-CMC 0.5% 
(c) Group 3: CP 50 mg/kg BW 
(d) Group 4: HcEE 250 mg/kg BW + CP 50 
mg/kg BW 
(e) Group 5: HcEE 500 mg/kg BW + CP 50 
mg/kg BW 
(f) Group 6: HcEE 1000 mg/kg BW + CP 50 
mg/kg BW 
(g) Group 7: HcEE 1000 mg/kg BW  
 
The treatment design is presented as shown as 
Table 1. All treatment groups were sampling 
peripheral blood through vein of tails at the 30 hours 
after giving CP. The blood specimens were made 
peripheral blood smear preparation on the 
microscope slides with smearing angle of 45
o
, then 
methanol was fixed for 15 minutes and after that 
stainined with Giemsa 10% in PBS pH 6.8 with 
incubation time 60 minutes. The preparation was 
cleaned using aquadest. After the preparation dried, 
preparation was closed by the cover slip using 
Entellen and observed the MNPCE, PCE, and NCE 
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The Marvinsketch program was utilized to 
make 3D phalerin and YASARA software was used 
for protein target preparation. PLANTS software 
was used for docking. The target protein choosed 
was CYP3A4 and the test compound used was 
ursolic acid and cyclophosphamid. The ursolic acid 
and cyclophosphamide ligand are then tethered to a 
protein that has been removed by its native ligand 
using the PLANTS program. Output obtained 
declare the force of ligand-receptor interaction in 
the form of docking scores. Visualization of amino 
acid residues that interact with receptors can be 




MNPCE observations were performed for 
every 2000 PCE cells, whereas %PCE calculations 
were performed on every 2000 total PCE and NCE 
(PCE + NCE) cells. MNPCE will be colored purple 
after Giemsa staining and has one or more 
micronucleus, PCE is purple and has no 
micronucleus, while NCE is not purple. 
Furthermore, statistical tests conducted using SPSS 
version 21. Statistical test begins with the test of data  
 
 
normality using Kolmogorov Smirnov. After it is 
known that the data is normally distributed, 
parametric statistic test was done with one way 
ANOVA followed by post-hoc Tuckey HSD test 
using 95% confidence level to know the significance 
of group. In addition, calculations of DNA damage 
reduction were done based on Waters et al. (1990) 





A : average number of MNPCE due to single 
treatment of CP 
B : average number of MNPCE due to  treatment of 
CP and HcEE 
C : average number of MNPCE due to untreated 
group 
 
The result of molecular docking was docking 
score between ursolic acid-CYP3A4 and 
cyclophosphamide- CYP3A4. If docking score 
ursolic acid-CYP3A4 is lower than 
cyclophosphamide- CYP3A4, it show that ursolic 
acid which probably contained in the HcEE will be 
potential antigenotoxic agent. 
 
 
Groups of treatment 
Day- 
1 2 3 4 5 6 7 
Group 1 
(Untreated) 
       
Group  2 
(Na-CMC 0.5%) 
       
Group  3 
(CP 50 mg/kg BW) 
       
Group  4 
(HcEE250 mg/kg BW + CP 50 
mg/kg BW) 
     
  
Group  5 
(HcEE 500 mg/kg BW + CP 
50 mg/kg BW ) 
     
  
Group  6 
(HcEE 1000 mg/kg BW + CP 
50 mg/kg BW ) 
       
Group  7 
(HcEE1000 mg/kg BW) 
       
%Reduction  = x 100 
A - B 
A - C 
: HcEE : Na-CMC 0.5% : CP 
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Identification of HcEE Phytochemical 
Content 
The TLC profile of HcEE shows the presence of 
pink spots on visible light with the color intensity 
and hRf (60) which is similar to the ursolic acid 
standard reference (Fig. 1). Hedyotis corymbosa L. 
contains pentacyclic triterpenoids of ursolic acid and 
oleanolic acid; the difference between the two lies 
only in the methyl group in the E ring. This 
phenomenon causes difficulty of separating both 
with the TLC system. The system of isocratic eluents 
certainly cannot separate the two. Based on this 
result, the pink spot on the TLC profile of HcEE 
may be a combination of ursolic acid and oleanolate 
























Determination of the Number of MNPCE 
and %PCE of Peripheral Blood 
Based on the results of this study, the 
observation of the appearance of MNPCE, PCE, and 
NCE cells of peripheral blood smear in Swiss strains 
mice induced cyclophosphamide represented in Fig. 
2. After Giemsa staining, MNPCE will be colored 
purple with micronucleus appearance on cytoplasm, 
while PCE is purple without micronucleus, and a 
gray NCE that can be observed under a light 
microscope. The number of MNPCE formed is a 
parameter of DNA damage. Observations of 
MNPCE, PCE, and NCE were performed on one 















Figure 2. Representative of cell appearace on 
pheripheral blood under treatment. 
Giemsa staining was performed and observed 
through a 1000x magnification light microscope 
(with immersion oil) and photographed using a 
digital camera. Red arrow (             ) showed 
each MNPCE, PCE, and NCE. 
 
 
The control group of 50 mg/kg BW of 
cyclophosphamide exhibit significantly the highest 
number of micronucleus (MNPCE) formation 
(p<0.05) by 90.5±7.44 (Table 2). This result 
suggests that cyclophosphamide has been shown to 
induce genotoxic effects. Animals tested with a 
single concentration of HcEE 1000 mg/kg BW (high 
risk) performed the strongest decrease in MNPCE 
(1.50±0.65). This phenomenon reveals that HcEE 
does not cause a genotoxic effect on its sole 
treatment. HcEE treatment with a variety of 
concentrations was shown to significantly decrease 
MNPCE against cyclophosphamide treatment. HcEE 
250, 500, and 1000 mg/kg BW were able to suppress 
the formation of MNPCE as a result of the 
cyclophosphamide induction at 35.5±3.80; 
6.50±1.85; and 2.75±0.85 (Fig. 3). 
Then we observed the number of nucleated 
red blood cell (PCE) to evaluate the effect of HcEE 
on blood differentiation. The %PCE parameter is the 
ratio of nucleated red blood cell used to assess the 
level of tested test substance given to the target cell. 
To measure the level of toxicity on bone marrow, 




Figure I. Thin chromatography profile of HcEE. 
Elution was performed with chloroform: 
acetone (9: 1 v / v) as mobile phase. The 
numbers 1 and 2 respectively are HcEE and 
ursolic acid standards. The TLC plate after 
spraying with 10% of H2SO4 in ethanol was 
then heated to 1100C for 5 min showed the 
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 (a)  (b) 
erythrocytes of peripheral blood (Krishna and 
Hayashi, 2000). Based on this study, the %PCE 
increase that occurred at all HcEE treatment 
concentration (250, 500, and 1000 mg/kg BW) were 
higher than in the cyclophosphamide treatment 
group. A single HcEE concentration of 1000 mg/kg 
BW also showed an increase in %PCE (7.36±0.92) 
(Table 2), so the HcEE used in this study was non-
toxic to erythroblasts in its sole treatment and was 
able to normalize %PCE.  
 
Molecular Docking 
 Molecular docking test protocol is done by 
referring to Purnomo (2011) using PLANTS 
software. The molecular docking test against 
CYP3A4 showed that native ligand, 
cyclophosphamide, and ursolic acid docking scores 
were -114; -74; and -88 (Table 3). The lower the 
docking score, the compound is predicted to interact 
more potent with the target protein. The ursolic acid 
has a lower docking score compared to 
cyclophosphamide, so it is thought that ursolic acid 
more potent interacts than cyclophosphamide to 
CYP3A4 despite the docking score of ursolic acid is 
greater than native ligand.  
Based on the 2D and 3D visualization results 
(Fig. 4), the interaction of ursolic acid with CYP3A4 
is shown by the similarity of the binding sites with 
the native ligand in the amino acid residues Ala 448, 
Ile 369, Thr 309 and Val 313 through hydrophobic 
bonds, whereas cyclophosphamide may interact with 
CYP3A4 via the binding site on the Ile 369 and Thr 
309 amino acid residues. Thus, the ursolic acid 
compound has a similar site attachment to more 
amino acid residues than between cyclophosphamide 
and native ligand. 
 
 
Table 2. Number of MNPCE and %PCE 
 
Groups 
Average of MNPCE ± 
S.E.M. 
Average of %PCE ± 
S.E.M. 
Reduction (%) 
Untreated 0.25±0.25 a, b 5.04±0.61 - 
Na-CMC 0.5% 1.75±1.03 a, b 3.24±0.60 - 
CP 90.50±7.44 b 2.81±0.30 - 
HcEE 250+CP 35.50±3.80 a 10.24±5.11 60.94 
HcEE 500+CP 6.50±1.85 a, b 3.53±0.32 85.29 
HcEE 1000+CP 2.75±0.85 a, b 3.72±0.31 98.87 
HcEE 1000 1.5±0.65 a, b 7.36±0.92 - 
  
 Explanation =  a: p<0,05 to CP; b: p<0,05 to HcEE 250+CP group 














Figure 3. Effect of HcEE on the peripheral blood profile. Peripheral blood smear was observed under a 1000x 
magnification light microscope (immersed oil), then calculated (a) MNPCE/ 2000 PCE and (b) % PCE = [PCE / (PCE + 
NCE)] with labels I : untreated, II : Na-CMC 0.5%, III : CP, IV : HcEE 250 mg/kg BW + CP, V : HcEE 500 mg/kg BW + 
CP, VI : HcEE 1000 mg/kg BW + CP, VII : HcEE 1000 mg/kg BW. The statistical test was performed using SPSS 
version 21 software with one way ANOVA method followed by Post Hoc Tuckey Test (p<0,05). The results are 
presented in the mean±SE (n = 4). Interconnection significance is indicated by asterisks (*) and (**) on the graph. Sign 
(*) shows significance to control of CP 50 mg/kg BW and sign (**) indicates significance to treatment group HcEE 250 
+ CP 50 mg/kg BW. 
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Figure 4.  Visualize 3D and 2D interactions between ligand and target protein CYP3A4 (PDB ID: 2V0M) using 
MOE 2010 applications. 3D interaction visualization (top image) and 2D (bottom image). The compound 
ketoconazole (native ligand) (a), cyclophosphamide (b), and ursolic acid (c) have a binding site on the same amino 
acid residues. The sign          denotes the similarity to the 370 amino acid residue. The sign           denotes residual 





This study was conducted to evaluate the 
potential of HcEE as an antigenotoxic agent in 
overcoming the effects of DNA damage. The 
active compound suspected of having 
antigenotoxic activity from rumput mutiara 
(Hedyotis corymbosa L.) is ursolic acid. Rumput 
mutiara is known to contain triterpenoids of ursolic 
acid and oleanolate (Khastgir, et al., 1960). The 
extraction process was carried out using 96% 
ethanol solvent because the active compound of 
ursolic acid is a relatively non-polarized 
triterpenoid group compound.  
HcEE is reported to have cytotoxic activity 
against some cancer cells in vitro. Suparman 
(2008) and Lee, et al. (2011) showed that HcEE 
was able to inhibit the proliferation of colon cancer 
cells WiDr and COLO 205, Hep3B liver cancer, 
and lung cancer H460. Other research from Chen, 
et al. (2006) mentioned that ursolic acid is active 
in MCF-7 cells with IC50 4.7 μg/mL, whereas 
oleanolic acid has very weak cytotoxic activity, 
even up to a concentration of 20 μg/mL gave only 
30% inhibition of cell viability. The ursolic acid is 
also reported to have an antigenotoxic effect on 
HepG2 in vitro (Ramos, et al., 2008). Based on 
these data, it can be predicted that ursolic acid 
plays a more dominant role than other compounds 
Ligands Docking score RMSD 
Ketoconazole (native ligand) -114 1.50Å 
Cyclophosphamide -74  
Ursolic acid -88  
 (c) 
 (a)  (b)  (c) 
 (a)  (b) 
Table 3. Score docking data of CYP3A4 target protein (2V0M) 
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contained in rumput mutiara herbs in mediating the 
antigenotoxic effects of HcEE. 
The animals for testing used in this study 
were mice with the consideration that granules 
mast cells in mice blood were found to be fewer 
than mice, making them more easily observed in 
the scoring process and would provide false 
positives (Jamura, et al., 2001; Pascoe and 
Gatehouse, 1986). Furthermore, data from The 
Collaborative Study Group for the Micronucleus 
Test (1986) mentioned that in general male mice 
are more sensitive than female mice to 
micronucleus induction, so in this study also used 
male mice.  
This study showed that in the treatment of 
cyclophosphamide with a concentration of 50 
mg/kg BW was the most significant increase in the 
amount of MNPCE that was formed. Meanwhile, 
in the treatment of HcEE concentrations of 250, 
500, or 1000 mg/kg BW with cyclophosphamide 
50 mg/kg BW, there was a significant decrease in 
frequency of MNPCE per 2000 PCE cells 
compared with cyclophosphamide control after 
one-way ANOVA with 95% confidence level. At 
the highest concentration, HcEE was able to 
decrease MNPCE up to 32.91 times and with a 
concentration of 500 mg/kg BW lowered the 
number of MNPCE by 13.92 times. 
The results of this study can be compared 
with previous research by Sugiyanto (2014) who 
tested antigenotoxic activity from secang ethanolic 
extract (Caesalpinia sappan L.) concentration 500 
mg/kg BW and 1000 mg/kg BW with 
cyclophosphamide treatment 50 mg/kg BW. 
Furthermore, at a concentration of 500 mg/kg BW, 
the secang wood extract reduced the MNPCE 
count by 3.5 times and at a concentration of 1000 
mg/kg BW could significantly decrease MNPCE 
by 20 times compared with cyclophosphamide 
control. Another study by Shabrina (2015) under 
the same treatment condition mentioned that 
papaya leaf ethanolic extract (Carica papaya L.) 
could decrease the number of MNPCE / 1000 PCE 
by 2.25 times at concentration of 500 mg/kg BW 
and 2.8 times at concentration highs.  
Genotoxic effects of cyclophosphamide 
arise after metabolism into active metabolites, 
namely phosphoramide mustard and acrolein. The 
genotoxic cyclophosphamide metabolite will 
attack the N7 atom from the guanine base residue 
on the DNA chain. The process will increase the 
crosslinking of the two DNA strands together 
(Brulikova, et al., 2012). The presence of these 
crosslinks will disrupt the function of nucleic acids 
and DNA synthesis and lead to the formation of 
micronucleus and cell death (Crook, et al., 1986; 
Tripathi and Jena, 2009; Bryce, et al., 2010). HcEE 
is known to contain triterpenoid compounds of 
ursolic acid which are believed to capture free 
radicals of cyclophosphamide metabolites. The 
content of ursolic acid in HcEE is thought to 
increase the levels of enzymatic and non-
enzymatic antioxidants (GSH) and inhibit 
cytochrome P450 (Liu, 1995; Martin-Arago, et al., 
2001; Saravanan, et al., 2005). However, the 
mechanism of ursolic acid in influencing the 
process of repairing DNA damage is not known for 
certain (Ferguson, 2001; Ferguson, et al., 2004). 
Treatment of cyclophosphamide 50 mg/kg 
BW caused a decrease in %PCE compared with 
other treatment groups. This is in accordance with 
the research of Jones, et al. (2001) that 
cyclophosphamide decreases the PCE ratio in 
peripheral blood. In the treatment of HcEE 
concentrations of 250, 500, and 1000 mg/kg BW, it 
has been shown to increase the value of %PCE in 
peripheral blood smear measurements observed on 
a single slide microscope. Increased %PCE 
parameters indicate a possible increase in 
erythrocytes production due to loss of adult 
erythrocytes (NCE), whereas a decrease in %PCE 
reflects a younger erythrocyte reshuffle (PCE) that 
has direct implications for erythrocyte production 
in bone marrow (Nathoo and Marshall, 2002). 
HcEE 250 mg/kg BW gave the highest %PCE 
among other treatment doses, although the 
treatment did not give significant difference to the 
doses of 500 or 1000 mg/kg BW based on 
statistical tests.  
In this research, molecular docking test was 
done to find out the possibility of interaction of 
ursolic acid compound with CYP34A target 
protein. Docking is a tethering interaction between 
ligands and proteins used to predict ligand position 
and orientation when bound to protein receptors 
(Girija, et al., 2010). Test ligand used in the form 
of ursolic acid and cyclophosphamide. While the 
native ligand is ketoconazole which is a powerful 
antifungal inhibitor of CYP3A4 (Ekroos and 
Sjögren, 2006). CYP3A4 was chosen as the target 
Aprianto, et al., 2017 




protein because it is one of the 450 cytochromes 
activating cyclophosphamide (Anonymous, 2013). 
When compared with cyclophosphamide, 
ursolic acid has a lower docking score, so it can be 
estimated that ursolic acid more potent interacts 
with CYP3A4 than cyclophosphamide. This result 
is reinforced by the visualization of interactions 
that can be observed in 3D and 2D in the receptor 
ligand-receptor area can only show hydrophobic 
and hydrogen bonds. Hydrophobic bonds play a 
role in determining ligand stability to receptors 
(Arwansyah et al., 2014). A greater number of 
hydrogen bonds show a greater interaction 
between ligand and receptor (Sarmoko, 2008). In 
the observation of interaction visualization showed 
the similarity of bond sites with native ligand on 
amino acid residues Ala 448, Ile 369, Thr 309, and 
Val 313, while cyclophosphamide has fewer 
similar sites, ie only on amino acid residue Ile 369 
and Thr 309. Thus, it can be concluded that ursolic 
acid can interact better with CYP3A4 target 
protein than cyclophosphamide.  
Overall, the results of this study have shown 
the antigenotoxic effect of HcEE with parameters 
of the amount of MNPCE and% PCE in 
cyclophosphamide induced mouse assay and 
computational method approach through molecular 
docking to see the interaction between ursolic acid 
and cyclophosphamide to CYP3A4 target protein. 
Further research is needed to determine dose 
optimization to ensure therapeutic effectiveness 
and development of appropriate dosage 




ERM 250, 500, and 1000 mg/kg BW were 
shown to provide antigenotoxic activity as 
indicated by a significant decrease in the number 
of MNPCE/2000 PCE and have a tendency to 
increase the %PCE value in Swiss strain- 
cyclophosphamide induced mice. Through the 
computational approach it is known that the ursolic 
acid compound can interact on CYP3A4 (PDB ID: 
2V0M) based on the lower docking score 
parameter (-88) than cyclophosphamide (-74) and 
the similarity of the connective site with native 
ligand in the amino acid residue Ala 448, Ile 369, 
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